HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

The effect of cephalothin prophylaxis on postoperative ventriculoperitoneal shunt infections.

Abstract
Postoperative infection is an important complication after insertion of a ventriculoperitoneal (VP) shunt in children with hydrocephalus. A randomized double-blind placebo-controlled study was performed to determine the efficacy of cephalothin in preventing postoperative shunt infection. Sixty-three children who presented for elective VP shunt insertion between January 1982 and December 1985 and who did not have a history of shunt infections were randomly assigned to receive four doses of prophylactic cephalothin, 25 mg/kg (32 patients), or of a multivitamin placebo (31 patients). Postoperative infection developed in 6% of the treatment group, compared with 10% of the placebo group, a difference that was not statistically significant, although a clinical significance may have been masked by the small sample size. A large multicentre trial is needed to determine the efficacy of antibiotic prophylaxis in reducing the incidence of postoperative VP shunt infections.
AuthorsM J Rieder, T C Frewen, R F Del Maestro, A Coyle, S Lovell
JournalCMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne (CMAJ) Vol. 136 Issue 9 Pg. 935-8 (May 01 1987) ISSN: 0820-3946 [Print] Canada
PMID3552176 (Publication Type: Clinical Trial, Journal Article, Randomized Controlled Trial)
Chemical References
  • Cephalothin
Topics
  • Bacterial Infections (prevention & control)
  • Cephalothin (administration & dosage, therapeutic use)
  • Cerebrospinal Fluid Shunts
  • Child
  • Child, Preschool
  • Clinical Trials as Topic
  • Double-Blind Method
  • Female
  • Humans
  • Hydrocephalus (surgery)
  • Infant
  • Infant, Newborn
  • Male
  • Peritoneal Cavity
  • Premedication
  • Random Allocation
  • Surgical Wound Infection (prevention & control)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: